Recruiting IgA Nephropathy Studies in Little Rock
About IgA Nephropathy Clinical Trials in Little Rock
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 1 iga nephropathy clinical trials recruiting participants in Little Rock, ARKANSAS. These studies are seeking a combined 454 participants. Research is being sponsored by Biogen. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Little Rock — FAQ
Are there iga nephropathy clinical trials in Little Rock?
Yes, there are 1 iga nephropathy clinical trials currently recruiting in Little Rock, ARKANSAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Little Rock?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.
Are clinical trials in Little Rock free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 1 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated March 2, 2026 from ClinicalTrials.gov